SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001062993-20-004414
Filing Date
2020-09-09
Accepted
2020-09-09 16:15:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 form424b5.htm 424B5 275734
2 GRAPHIC form424b5x001.jpg GRAPHIC 8963
  Complete submission text file 0001062993-20-004414.txt   289175
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237810 | Film No.: 201166679
SIC: 2834 Pharmaceutical Preparations